A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolaemia in South Asian Subjects

Trial Profile

A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolaemia in South Asian Subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2008

At a glance

  • Drugs Atorvastatin; Rosuvastatin
  • Indications Hypercholesterolaemia; Hyperlipidaemia
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms IRIS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 17 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top